Warning: This security is no longer trading.
defunct
Retrophin, Inc. (RTRX): Price and Financial Metrics
RTRX Price/Volume Stats
| Current price | $24.25 | 52-week high | $24.96 |
| Prev. close | $24.36 | 52-week low | $8.98 |
| Day low | $24.04 | Volume | 378,900 |
| Day high | $24.74 | Avg. volume | 412,277 |
| 50-day MA | $20.67 | Dividend yield | N/A |
| 200-day MA | $17.78 | Market Cap | 1.24B |
RTRX Stock Price Chart Interactive Chart >
Retrophin, Inc. (RTRX) Company Bio
Retrophin focuses on the development, acquisition, and commercialization of therapies for the treatment of serious, catastrophic, or rare diseases, including focal segmental glomerulosclerosis (FSGS), pantothenate kinase-associated neurodegeneration (PKAN), infantile spasms, nephrotic syndrome and others. The company was founded in 2011 and is based in San Diego, California.
RTRX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 77.27% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -37.25% |
Continue Researching RTRX
Want to do more research on Retrophin Inc's stock and its price? Try the links below:Retrophin Inc (RTRX) Stock Price | Nasdaq
Retrophin Inc (RTRX) Stock Quote, History and News - Yahoo Finance
Retrophin Inc (RTRX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...